As of Oct 17
| -0.35 / -2.36%|
The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 11.00, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a -24.14% decrease from the last price of 14.50.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.